Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Immunoadsorption successfully treated a man's resistant polymyositis.

Live imaging helps us understand skin immune responses and develop treatments.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Immunological treatment improved both neuropathy and alopecia.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

COVID-19 and its vaccine can cause skin issues, but most are minor and resolve on their own.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Vitamin D made by the skin plays a role in immune defense and skin health, and more research is needed to understand its full effects.